about
Fetal aortic arch measurements at 14 to 40 weeks' gestation derived by spatiotemporal image correlation volume data sets.Prenatal sonographic findings associated with asphyxiating thoracic dystrophy (Jeune syndrome).Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.Fetal anaemia from red blood cell membrane defect and co-inherited haemoglobin Constant SpringAdenomyosis in pregnancy mimicking morbidly adherent placenta.Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment.Cardio-STIC Based Reference Ranges of Fetal Thymus Size in Singleton Pregnancies.Hemodynamic assessment of hydrops foetalis secondary to transient myeloproliferative disorder associated with foetal Down syndrome: A case report and literature review.Reference ranges of placental volume measured by virtual organ computer-aided analysis between 10 and 14 weeks of gestation.Sonographic findings in an isolated widened fetal subarachnoid space.Pregnancy Outcomes Among Women with Homozygous Hemoglobin E Disease: A Retrospective Cohort Study.Randomized controlled trial comparing efficacy between a vaginal misoprostol loading and non-loading dose regimen for second-trimester pregnancy termination.Randomized controlled study comparing misoprostol moistened with normal saline and with acetic acid for second-trimester pregnancy termination. Is it different?Outcomes of pregnancy with gestational diabetes mellitus.Pregnancy outcomes among mothers aged 15 years or less.Association of first-trimester pregnancy-associated plasma protein A levels and idiopathic preterm delivery: A population-based screening study.Pregnancy outcomes among women with beta-thalassemia trait.Pregnancy outcomes among women with hemoglobin E trait.Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.Prenatal strategies for reducing severe thalassemia in pregnancy.Pregnancy outcomes among chronic carriers of hepatitis B virus.A comparison of the accuracy of the corpuscular fragility and mean corpuscular volume tests for the alpha-thalassemia 1 and beta-thalassemia traits.Fetal myocardial performance (Tei) index in fetal hemoglobin Bart's disease.Intrauterine treatment for an acardiac twin with alcohol injection into the umbilical artery.Reference ranges of ductus arteriosus derived by cardio-spatiotemporal image correlation from 14 to 40 weeks of gestation.Reference ranges for fetal septum primum excursion from 14 to 40 weeks' gestation.A comparison of 100 microg oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial.Misoprostol for second trimester termination of pregnancies with prior low transverse cesarean section.Outcomes of pregnancies affected by hemoglobin H disease.Recurrent impetigo herpetiformis successfully treated with methotrexate: a case report.Normal reference ranges of inferior vena cava doppler indices from 14 to 40 weeks of gestation.Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol.Comparison of the accuracy of dichlorophenolindophenol (DCIP), modified DCIP, and hemoglobin E tests to screen for the HbE trait in pregnant women.Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.Fetal ventricular shortening fraction in hydrops fetalis.A comparison of labor induction by oral and vaginal misoprostol.Predisposing factors and effects of fetal bradycardia following cordocentesis at mid-pregnancy.Amniocentesis in twin pregnancies.Comparison of fetal cardiac spatiotemporal image correlation segmental analysis between cardiac- and body-based scrolling.Spinal tuberculosis in pregnancy.
P50
Q33516474-0212374E-5CDA-4F21-AFB4-33BF0B3FA7CFQ33870962-07B1B2EF-5ADE-4F2D-AABD-B341B98459CBQ33925215-3F5B9482-13E6-457B-A487-22B95325E8B1Q35906850-C42891B4-DF42-4671-BD34-101F4EF0542BQ37703629-69234335-0A2D-4FA3-946E-4BC2F67798A4Q38748136-012B1682-DA4D-4E46-B838-4333BD9E4722Q38948667-9B318793-CA50-441E-A018-CA7D7BE8FACAQ38950355-37EC4AF5-0F23-480A-B295-45C45E772DB1Q38977553-F8CF4B63-1859-4893-B00B-5CBFD9B910E8Q39014241-99AF02DB-61D3-4FF4-B288-8552DA4E50F1Q39561655-75A35D58-6B39-41F2-B248-E82F2892C442Q40234680-4CD3C269-85BD-4A68-BD5F-CF71674B27D0Q40330801-888EA598-EE78-443B-B0B5-DF1248101EF5Q40537573-FC32D29A-97B6-468A-8359-1082A376FAB4Q40603636-9F98F5BB-6DEF-42CB-8190-8B7B595B9304Q40880396-C31D9F5C-FDC0-498C-9548-D7B1476E2751Q41206197-7BD79149-617A-4F9F-9C64-B767D597BC1EQ41274916-74DEAB7F-217F-4902-82DC-2CFC36F2A9DBQ41363097-D1941656-EA33-416C-A2DD-DA851FD20F0CQ41739638-6A437CA5-34D5-4C9B-AC1F-C089E0785476Q42215006-7BFEEE59-75CC-4B8A-A461-C7F6AD569E2DQ43596544-7B652CAF-4161-4137-A4FB-4AAD530B3418Q43686637-10983862-3B3C-4BBD-8FBE-BF5A7F2BF0DCQ44037967-930B48EC-2CB1-436E-A931-15ED07B009F3Q44133199-EEA81D80-305A-46F8-81A7-427A2E0989A2Q44254174-C84BC74B-85DF-4598-A352-A832DB6C8A76Q44269683-FCABBE7F-6FF7-4A7E-B81C-F454E4A20236Q44278055-5186C7E7-B43B-459F-A5A4-6FC4405BA9D2Q44407520-2EF91E98-5AB1-430E-96C3-E36520B6B89AQ44600150-A3B7219B-E408-45F6-B2F2-3BB1070E5A7BQ44630440-C9DFED68-0BF0-42A2-AC71-B8808A6567A4Q44946557-85BE8D51-E0E9-42D0-B4AF-61418DF70015Q44959247-E92FC59B-0F27-4F8F-B0D3-6463247538EAQ45027762-11055CFD-DB49-4334-A547-A78D5EABA52FQ45055105-1EAEF5EE-6619-4A48-86D2-9E4978E65614Q45252593-D28E9881-5756-4968-AA68-4F97C9B3056BQ46024664-3A7EDD80-2536-4D87-80DC-A00042AE2020Q46148312-467BD8DB-83CE-4F7A-A1AC-CD3983C18503Q46318269-D48059C5-62E5-4AC8-9426-85B807667C8DQ46555980-70B05E48-28A4-48B9-B8A7-3DC5404B5360
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Theera Tongsong
@ast
Theera Tongsong
@en
Theera Tongsong
@es
Theera Tongsong
@nl
type
label
Theera Tongsong
@ast
Theera Tongsong
@en
Theera Tongsong
@es
Theera Tongsong
@nl
prefLabel
Theera Tongsong
@ast
Theera Tongsong
@en
Theera Tongsong
@es
Theera Tongsong
@nl
P106
P1153
7004980902
P31
P496
0000-0002-3389-6478